PERSPECTA

News from every angle

Back to headlines

AtaiBeckley Shares Soar on Eli Lilly Buyout Talks

Shares of psychedelic drugmaker AtaiBeckley surged by 66% following reports of potential buyout discussions with pharmaceutical giant Eli Lilly.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.